You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

About DrugChatter

DrugChatter is a product of thinkBiotech LLC, and is managed by Yali Friedman, Ph.D.

Dr. Friedman was also publisher and chief editor of the Journal of Commercial Biotechnology for many years. His first book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development.

Dr. Friedman has strong exposure to leading issues in international biotechnology. He is lead editorial consultant for Scientific American's worldVIEW, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC and for individual countries such as Japan, Canada, Germany, the Philippines, and Turkey.

Connect on LinkedIn

DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.